Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Human FcRn Tissue Expression Profile and Half-Life in PBMCs.

Fan YY, Farrokhi V, Caiazzo T, Wang M, O'Hara DM, Neubert H.

Biomolecules. 2019 Aug 15;9(8). pii: E373. doi: 10.3390/biom9080373.

2.

Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXaI16L in Preclinical Species.

Parng C, Bolt M, Pittman DD, Caiazzo T, Dyleski L, Gorovits B, Webster R.

AAPS J. 2019 Apr 11;21(3):52. doi: 10.1208/s12248-019-0324-z.

PMID:
30976993
3.

Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody.

Xiang Y, Parng C, Olson K, Seletskaia E, Gorovits B, Jani D, Caiazzo T, Joyce A, Donley J.

AAPS J. 2019 Mar 29;21(3):46. doi: 10.1208/s12248-019-0320-3.

PMID:
30927117
4.

Approaches to Resolve False Reporting in Neutralizing Antibody Assays Caused by Reagent Leaching from Affinity Capture Elution Solid Phase.

Xiang Y, Kamerud J, Donley J, Olson K, Caiazzo T, Yeung D, Parng C, Gorovits B.

AAPS J. 2018 Nov 6;21(1):4. doi: 10.1208/s12248-018-0274-x.

PMID:
30402825
5.

Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor XaI16L.

Parng C, Markiewicz V, Chen J, Leary B, Duriga N, Dyleski L, Caiazzo T, Bolt M, Joyce A, Gorovits B, Pittman DD, Webster R.

J Pharm Sci. 2017 Aug;106(8):2136-2143. doi: 10.1016/j.xphs.2017.03.035. Epub 2017 Apr 5.

PMID:
28389265
6.

Orally active fumagillin analogues: transformations of a reactive warhead in the gastric environment.

Arico-Muendel CC, Blanchette H, Benjamin DR, Caiazzo TM, Centrella PA, DeLorey J, Doyle EG, Johnson SR, Labenski MT, Morgan BA, O'Donovan G, Sarjeant AA, Skinner S, Thompson CD, Griffin ST, Westlin W, White KF.

ACS Med Chem Lett. 2013 Feb 22;4(4):381-6. doi: 10.1021/ml3003633. eCollection 2013 Apr 11.

7.

Metabolites of PPI-2458, a selective, irreversible inhibitor of methionine aminopeptidase-2: structure determination and in vivo activity.

Arico-Muendel CC, Belanger B, Benjamin D, Blanchette HS, Caiazzo TM, Centrella PA, DeLorey J, Doyle EG, Gradhand U, Griffin ST, Hill S, Labenski MT, Morgan BA, O'Donovan G, Prasad K, Skinner S, Taghizadeh N, Thompson CD, Wakefield J, Westlin W, White KF.

Drug Metab Dispos. 2013 Apr;41(4):814-26. doi: 10.1124/dmd.112.048355. Epub 2013 Jan 25.

PMID:
23355637
8.

Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.

Arico-Muendel CC, Benjamin DR, Caiazzo TM, Centrella PA, Contonio BD, Cook CM, Doyle EG, Hannig G, Labenski MT, Searle LL, Lind K, Morgan BA, Olson G, Paradise CL, Self C, Skinner SR, Sluboski B, Svendsen JL, Thompson CD, Westlin W, White KF.

J Med Chem. 2009 Dec 24;52(24):8047-56. doi: 10.1021/jm901260k.

PMID:
19929003
9.

Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

Gritz L, Destree A, Cormier N, Day E, Stallard V, Caiazzo T, Mazzara G, Panicali D.

J Virol. 1990 Dec;64(12):5948-57.

10.

Expression of Mycobacterium tuberculosis and Mycobacterium leprae proteins by vaccinia virus.

Lyons J, Sinos C, Destree A, Caiazzo T, Havican K, McKenzie S, Panicali D, Mahr A.

Infect Immun. 1990 Dec;58(12):4089-98.

11.

Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivatives.

Johnson M, Caiazzo T, Molina JM, Donahue R, Groopman J.

Br J Haematol. 1988 Oct;70(2):137-41.

PMID:
2847772
12.

Lack of evidence of prolonged human immunodeficiency virus infection before antibody seroconversion.

Groopman JE, Caiazzo T, Thomas MA, Ferriani RA, Saltzman S, Moon M, Seage G, Horsburgh CR Jr, Mayer K.

Blood. 1988 Jun;71(6):1752-4.

PMID:
3370318

Supplemental Content

Loading ...
Support Center